Phase I Trial of Dose-Escalated Whole Liver Irradiation with Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients with Neuroendocrine Hepatic Metastases

OBJECTIVES: We have previously shown that refractory neuroendocrine tumors can respond to moderate doses of chemoradiotherapy. We completed a dose-escalation phase I/II trial combining hepatic arterial (HA) chemotherapy, chemoembolization, and dose-escalated whole liver radiotherapy (WLRT) to determ...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Am J Clin Oncol
Huvudupphovsmän: Shilkrut, Mark, Sapir, Eli, Hanasoge, Sheela, Schipper, Matthew J., Normolle, Daniel P., Ben-Josef, Edgar, Ensminger, William, Lawrence, Theodore S., Feng, Mary
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4985493/
https://ncbi.nlm.nih.gov/pubmed/26886946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000276
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk